Siegfried Holding AG (SFZN)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Siegfried Holding AG (SFZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012234
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. The company also offers development and production services for finished dosage forms including sterile filling. Siegfried serves principally companies operating in pharmaceutical industry. It has production facilities in the USA, Switzerland, Malta, China, Germany and France. The company offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Switzerland.

Siegfried Holding AG (SFZN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Debt Offering 10
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 10
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 11
Siegfried Holding Raises USD61.33 Million in Bonds Offering 12
Acquisition 13
Siegfried Acquires Hameln Pharma for USD62 Million 13
Siegfried Acquires Alliance Medical Products For US$58 Million 15
Siegfried Holding AG – Key Competitors 16
Siegfried Holding AG – Key Employees 17
Siegfried Holding AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Financial Announcements 20
Aug 23, 2017: Siegfried Reports Higher Profit and Increased Margin for First Six Months 20
Mar 14, 2017: Siegfried with Jump in Sales in 2016 21
Aug 18, 2016: Siegfried with Jump in Sales 22
Mar 22, 2016: Siegfried with Record Sales in 2015 24
Corporate Communications 26
Mar 21, 2017: Siegfried Group: Management Changes 26
Mar 09, 2016: Siegfried: Ulla Schmidt and Martin Schmid recommended for nomination to the Board of Directors 27
Legal and Regulatory 28
Jun 27, 2016: Chinese authorities issued operating approval to Siegfried Nantong 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Siegfried Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siegfried Holding AG, Deals By Therapy Area, 2011 to YTD 2017 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 10
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 11
Siegfried Holding Raises USD61.33 Million in Bonds Offering 12
Siegfried Acquires Hameln Pharma for USD62 Million 13
Siegfried Acquires Alliance Medical Products For US$58 Million 15
Siegfried Holding AG, Key Competitors 16
Siegfried Holding AG, Key Employees 17
Siegfried Holding AG, Subsidiaries 18

★海外企業調査レポート[Siegfried Holding AG (SFZN)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • N V Nederlandse Gasunie:企業の戦略・SWOT・財務情報
    N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report Summary N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank of Jordan (BOJX):企業の財務・戦略的SWOT分析
    Summary Bank of Jordan is a banking service provider. The company offers corporate services, leasing services, retail services, SMEs services and securities services. It also provides car loans, mortgage, personal loans and credit cards. Bank of Jordan’s retail services include accounts and deposits …
  • Tesco Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Tesco Corp (Tesco), a subsidiary of Nabors Industries Ltd, is an oilfield technologies company. It sells and rents top drives and automated pipe handling equipment; and offers tubular services, including related products and accessories sales and aftermarket sales and services. The company o …
  • General Atomics:企業の戦略・SWOT・財務情報
    General Atomics - Strategy, SWOT and Corporate Finance Report Summary General Atomics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Greggs Plc:企業の戦略・SWOT・財務情報
    Greggs Plc - Strategy, SWOT and Corporate Finance Report Summary Greggs Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • British Polythene Industries Plc:企業の戦略・SWOT・財務分析
    British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report Summary British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Jiangsu Jiuding New Material Co Ltd (002201):企業の財務・戦略的SWOT分析
    Jiangsu Jiuding New Material Co Ltd (002201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Oman Air (SAOC):企業の戦略・SWOT・財務情報
    Oman Air (SAOC) - Strategy, SWOT and Corporate Finance Report Summary Oman Air (SAOC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Dow Chemical Co-エネルギー分野:企業M&A・提携分析
    Summary The Dow Chemical Company (Dow), a subsidiary of DowDupont is a diversified chemical company. Its businesses encompass specialty chemicals, advanced materials, agrosciences and plastics. The company manufactures and supplies products used primarily as raw materials in the manufacture of custo …
  • Digital China Holdings Limited:企業の戦略・SWOT・財務分析
    Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Titan Pharmaceuticals Inc (TTNP):医療機器:M&Aディール及び事業提携情報
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • Jack Henry & Associates Inc (JKHY):企業の財務・戦略的SWOT分析
    Jack Henry & Associates Inc (JKHY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Goodwin Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd, is a biological contract development and manufacturing organization that offers antibody drug conjugates, radioimmunoconjugates, and other protein bioconjugates. The organization offers cell culture, purificati …
  • Takaful Emarat – Insurnace (P.S.C):企業の戦略・SWOT・財務情報
    Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report Summary Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Korea Research Institute of Bioscience and Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute which provides bioinformatic services. The institute operates in the fields of strategic research, biomedical sciences, system biology and bioengineering, business development, and bioinfrastr …
  • W. L. Gore & Associates Inc-医療機器分野:企業M&A・提携分析
    Summary W. L. Gore & Associates Inc (Gore) is a manufacturer and distributor of fluoropolymer products. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company has developed numerous products for medica …
  • Eskom Holdings SOC Ltd:電力:M&Aディール及び事業提携情報
    Summary Eskom Holdings SOC Ltd (Eskom) is a state-owned power utility that generates, transmits and distributes electricity. It generates electricity from coal-fired, gas-fired, hydro and pumped storage power plants, and nuclear power plants, among others. The company supplies electricity to industr …
  • Serica Energy Plc:企業のM&A・事業提携・投資動向
    Serica Energy Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Serica Energy Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Sky plc (SKY):企業の財務・戦略的SWOT分析
    Sky plc (SKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Coty Inc.:企業の戦略・SWOT・財務分析
    Coty Inc. - Strategy, SWOT and Corporate Finance Report Summary Coty Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆